Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Given Average Recommendation of “Reduce” by Brokerages

Shares of Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) have earned a consensus rating of “Reduce” from the nine research firms that are covering the company, MarketBeat Ratings reports. Four investment analysts have rated the stock with a sell recommendation and five have assigned a hold recommendation to the company. The average 12-month target price among analysts that have updated their coverage on the stock in the last year is $28.00.

FMS has been the topic of a number of research analyst reports. Wall Street Zen lowered shares of Fresenius Medical Care AG & Co. KGaA from a “buy” rating to a “hold” rating in a research report on Saturday, May 9th. Morgan Stanley reiterated an “underweight” rating on shares of Fresenius Medical Care AG & Co. KGaA in a report on Wednesday, May 6th. Zacks Research upgraded Fresenius Medical Care AG & Co. KGaA from a “strong sell” rating to a “hold” rating in a research note on Monday, July 6th. Jefferies Financial Group raised Fresenius Medical Care AG & Co. KGaA from a “strong sell” rating to a “moderate sell” rating in a report on Friday, May 8th. Finally, Citigroup restated a “neutral” rating on shares of Fresenius Medical Care AG & Co. KGaA in a research report on Friday, April 24th.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the company. AQR Capital Management LLC increased its stake in Fresenius Medical Care AG & Co. KGaA by 14.2% in the first quarter. AQR Capital Management LLC now owns 14,297 shares of the company’s stock valued at $356,000 after purchasing an additional 1,777 shares in the last quarter. JPMorgan Chase & Co. grew its stake in Fresenius Medical Care AG & Co. KGaA by 160.3% in the second quarter. JPMorgan Chase & Co. now owns 37,610 shares of the company’s stock valued at $1,075,000 after acquiring an additional 23,163 shares during the period. American Century Companies Inc. increased its holdings in shares of Fresenius Medical Care AG & Co. KGaA by 21.3% during the second quarter. American Century Companies Inc. now owns 29,173 shares of the company’s stock valued at $833,000 after acquiring an additional 5,127 shares in the last quarter. Russell Investments Group Ltd. increased its holdings in shares of Fresenius Medical Care AG & Co. KGaA by 21.3% during the second quarter. Russell Investments Group Ltd. now owns 5,096 shares of the company’s stock valued at $146,000 after acquiring an additional 896 shares in the last quarter. Finally, EverSource Wealth Advisors LLC raised its position in shares of Fresenius Medical Care AG & Co. KGaA by 141.8% during the second quarter. EverSource Wealth Advisors LLC now owns 2,906 shares of the company’s stock worth $83,000 after purchasing an additional 1,704 shares during the period. Institutional investors own 8.37% of the company’s stock.

Fresenius Medical Care AG & Co. KGaA Price Performance

NYSE FMS traded up $0.12 during midday trading on Friday, hitting $24.03. The company had a trading volume of 311,961 shares, compared to its average volume of 561,445. The company has a market capitalization of $12.91 billion, a PE ratio of 12.65, a P/E/G ratio of 4.33 and a beta of 0.78. The company has a current ratio of 1.20, a quick ratio of 0.86 and a debt-to-equity ratio of 0.40. The firm has a 50-day moving average price of $22.47 and a 200-day moving average price of $22.85. Fresenius Medical Care AG & Co. KGaA has a twelve month low of $20.02 and a twelve month high of $27.64.

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) last issued its earnings results on Tuesday, March 31st. The company reported $1.05 EPS for the quarter. Fresenius Medical Care AG & Co. KGaA had a net margin of 4.88% and a return on equity of 8.90%. The company had revenue of $5.34 billion during the quarter. As a group, analysts anticipate that Fresenius Medical Care AG & Co. KGaA will post 2.24 earnings per share for the current fiscal year.

Fresenius Medical Care AG & Co. KGaA Increases Dividend

The business also recently announced an annual dividend, which was paid on Monday, June 8th. Investors of record on Friday, May 22nd were given a dividend of $0.8716 per share. The ex-dividend date of this dividend was Friday, May 22nd. This represents a yield of 402.0%. This is an increase from Fresenius Medical Care AG & Co. KGaA’s previous annual dividend of $0.79. Fresenius Medical Care AG & Co. KGaA’s dividend payout ratio is 31.58%.

Fresenius Medical Care AG & Co. KGaA Company Profile

Fresenius Medical Care AG & Co KGaA is the world’s largest integrated provider of products and services for individuals with renal diseases. The company’s primary business activities encompass the operation of dialysis clinics and the manufacture and distribution of dialysis equipment, dialysis machines, dialyzers, consumables and related therapies. Through its global network of clinics, Fresenius Medical Care delivers comprehensive kidney care, including hemodialysis and peritoneal dialysis treatments, patient education and support services.

In its products segment, the company designs and produces dialysis machines, water treatment systems and disposables such as high‐flux dialyzers and bloodlines.